peoniflorin
Small moleculeexperimental
Paeoniflorin is a chemical compound which is one of the major constituents of an herbal medicine derived from Paeonia lactiflora. It can also be isolated from the fresh water fern Salvinia molesta. — Wikipedia
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Nov 1, 2004 (NCT01600521)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaPaeoniflorin ↗
Also known as
- 5b-((benzoyloxy)methyl)tetrahydro-5-hydroxy-2-methyl-2,5-methano-lh-3,4-dioxacyclobuta(cd) pentalen-1a(2h)-yl-beta-d-glucopyranoside
- paeoniflorin
- paeoniflorin
- paeoniflorin
- peoniflorin
- peoniflorin
- peoniflorin sulfonate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02878863 | Phase 3 | Aug 1, 2016 | Sichuan University, West China Hospital |
| NCT01600521 | N/A | Nov 1, 2004 | University of Minnesota |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sichuan University | Academic/Hospital | 1 | 0 | 1 | 2016 |
| University of Minnesota | Academic/Hospital | 1 | 1 | 1 | 2004 |
| West China Hospital | Academic/Hospital | 1 | 1 | 1 | 2016 |
3 organizations
Page 1 / 1